Three former Palantir AI execs founded Perceptic, which is getting funding from Accel, Air Street Capital, and Elder Gull.

Recursion Pharmaceuticals (NASDAQ: RXRX) is doing so specifically within the biotech niche, but the company's efforts haven't ...

Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have ...

Astellas Pharma Inc. will lean on high-margin brands like cancer drug Padcev and eye treatment Izervay to reach a five-year ...

Obesity assets represent about 25% of total forecast sales of the late-stage pipeline, while oncology's share has slipped to 20%, Deloitte found.

Investors have piled into pharma and biotech companies involved in the obesity drug space in recent years -- and for good ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized rare disease products and entry into the U.S.

The space startup is collaborating with United Therapeutics Corporation to manufacture commercial drugs in orbit.

The pharma giant is taking steps to expand its portfolio.

Shares of Corbus Pharmaceuticals dropped after the biotechnology company reported data from its clinical study of a tumor treatment that showed adverse events among some patients. The stock slid 31%, ...

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a ...